Cargando…
Long-Term Outcome of a Series of Patients With Narcolepsy Type 1 and Comorbidity With Immunopathological and Autoimmune Diseases
BACKGROUND: The aim of this study was to evaluate the long-term outcome of our series of narcolepsy type 1 (NT1) patients with comorbid autoimmune diseases (ADs) and other immunopathological diseases (IDs), focusing on the incidence of new ADs and IDs in this sample. METHODS: A longitudinal observat...
Autores principales: | Martinez-Orozco, Francisco J., Fernandez-Arquero, Miguel, Vicario, Jose L., Lillo-Triguero, Laura, Ameyugo, Elena, Peraita-Adrados, Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451554/ https://www.ncbi.nlm.nih.gov/pubmed/36128006 http://dx.doi.org/10.14740/jocmr4758 |
Ejemplares similares
-
Comorbidity of Narcolepsy Type 1 With Autoimmune Diseases and Other Immunopathological Disorders: A Case-Control Study
por: Martinez-Orozco, Francisco Javier, et al.
Publicado: (2016) -
Long-term follow-up on the effects of sodium oxybate on daytime sleepiness and sleep architecture in patients with narcolepsy type 1
por: Peraita-Adrados, Rosa, et al.
Publicado: (2023) -
Efecto a largo plazo del oxibato de sodio en la somnolencia diurna y en la estructura del sueño en pacientes con narcolepsia de tipo 1
por: Peraita-Adrados, Rosa, et al.
Publicado: (2023) -
Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning
por: Zhang, Zhongxing, et al.
Publicado: (2018) -
Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy
por: Ollila, Hanna M., et al.
Publicado: (2023)